Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.6671
-0.1578 (-19.13%)
Jan 28, 2026, 12:40 PM EST - Market open
Jupiter Neurosciences Employees
Jupiter Neurosciences had 4 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,899,373
Market Cap
22.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| Werewolf Therapeutics | 39 |
| Palatin Technologies | 29 |
| AN2 Therapeutics | 22 |
| Outlook Therapeutics | 17 |
| NeuroSense Therapeutics | 17 |
| Skye Bioscience | 16 |
| Serina Therapeutics | 13 |
JUNS News
- 1 day ago - Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference - Accesswire
- 5 weeks ago - Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 - GlobeNewsWire
- 2 months ago - Jupiter Neurosciences to Participate in NobleCon21 - Newsfile Corp
- 3 months ago - Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing - GlobeNewsWire
- 5 months ago - Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador - GlobeNewsWire
- 6 months ago - Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science - GlobeNewsWire
- 7 months ago - Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 7 months ago - Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery - GlobeNewsWire